Home » Diseases » In dogs » Multiple Myeloma (Bone Marrow Cancer)

Multiple Myeloma (Bone Marrow Cancer) in Dogs

Occurrence: very rare
Location of illness: General/Whole body

Multiple myeloma is a malignant cancer of the bone marrow in dogs, characterized by the uncontrolled proliferation of plasma cells. These cells are part of the immune system and normally produce antibodies, but in multiple myeloma, abnormal, non-functional antibodies are produced, which can lead to various health problems.

The most important facts at a glance

Multiple myeloma is a form of bone marrow cancer in dogs in which there is an uncontrolled proliferation of plasma cells that produce antibodies. The exact cause is not fully known, but genetic factors, environmental factors, and chronic inflammatory conditions may play a role. This disease leads to the production of monoclonal proteins that can damage organs such as the kidneys, cause coagulopathies, and weaken the immune system. Symptoms include pain, lameness, weakness, fever, respiratory distress, and tendency to bleed. Diagnosis is made through clinical examinations, blood tests, electrophoresis, and imaging procedures such as X-rays. A bone marrow biopsy may be required for confirmation.

Treatment involves chemotherapy, supportive care, and symptomatic treatments to control the growth of cancer cells. Medications such as melphalan and prednisone are commonly used, and bisphosphonates can help support bone health. The prognosis depends on the stage of the disease and the response to treatment, with survival time typically ranging from 12 to 18 months. Since the causes are not fully known, there are no specific preventive measures, but regular veterinary check-ups can help to detect the disease early.

Current research focuses on the genetic and molecular mechanisms that cause multiple myeloma in dogs, as well as on new treatment methods such as immunotherapies. The goal is to develop personalized medicine to make treatment more effective and minimize side effects.

Causes

The bone marrow is the tissue inside the bones where blood cells, including plasma cells, are formed. Plasma cells are a type of white blood cell that originate from B lymphocytes and are responsible for producing antibodies. In multiple myeloma, there is a clonal expansion of these cells, meaning that a single cell grows and multiplies uncontrollably.

The exact cause of multiple myeloma in dogs is not fully understood. It is believed that genetic factors may play a role, as certain dog breeds are more commonly affected. Environmental factors and chronic inflammatory conditions may also contribute to the development of the disease.

An important aspect of the pathogenesis of multiple myeloma is the production of monoclonal proteins or paraproteins, which circulate in the blood and can damage various organs. These proteins can impair normal kidney function, lead to blood clotting disorders, and weaken the immune system.

Symptoms

Very common symptoms:

Common symptoms:

Rare symptoms:

The symptoms of multiple myeloma in dogs are often non-specific and can vary depending on the organ affected. The most common signs include lethargy, weakness, and loss of appetite. Dogs may also drink and urinate excessively, which indicates kidney involvement.

Bone pain and lameness are also common, as the diseased cells in the bone marrow can damage the surrounding bone tissue, which can lead to fractures. In addition, blood clotting disorders can occur, which manifest as bleeding or bruising.

Some dogs develop neurological symptoms such as weakness or paralysis if the disease spreads to the nervous system. Eye symptoms such as retinal detachments are also possible if the blood supply to the eyes is disrupted.

Diagnosis

Diagnosis of multiple myeloma in dogs requires a combination of clinical examinations, blood tests, and imaging procedures. A complete blood count may reveal anemia, thrombocytopenia, or an increased number of white blood cells. A biochemical profile can detect kidney dysfunction and high calcium levels in the blood.

Electrophoresis tests of serum or urine are used to identify the presence of monoclonal proteins. These tests can visualize the abnormal antibodies produced by the plasma cells. A bone marrow biopsy is often required to confirm the diagnosis and determine the number of plasma and myeloma cells.

Imaging techniques such as X-rays, ultrasound, or MRI can help detect bone lesions, tumor growth, or organ involvement. These examinations are important to determine the extent of the disease and the affected areas.

Therapy

Treatment for multiple myeloma in dogs typically involves a combination of chemotherapy, supportive care, and symptomatic treatment. Chemotherapeutic drugs such as melphalan and prednisone are commonly used agents that can inhibit the growth of cancer cells and reduce their number.

In addition, treatment with bisphosphonates can help support bone health and relieve pain. These medications work by inhibiting bone resorption and improving bone strength.

Symptomatic treatments may include the administration of analgesics, the correction of anemia, or the treatment of kidney failure. Regular monitoring of blood cells and organ functions is also important to monitor the course of the disease and adjust therapy accordingly.

Prognosis and follow-up care

The prognosis for dogs with multiple myeloma varies considerably and depends on several factors, including the stage of the disease, the response to treatment, and the presence of complications. In general, the disease can be controlled with appropriate therapy, but it is considered incurable.

The median survival time after diagnosis is typically between 12 and 18 months, but may be shorter or longer depending on the individual response to treatment. Early diagnosis and a well-coordinated treatment plan can significantly improve the quality of life and extend survival time.

Prevention

Since the exact causes of multiple myeloma in dogs are not fully known, there are no specific preventive measures that can reliably prevent the development of the disease. However, general health monitoring and regular veterinary check-ups can help to detect and treat the disease early.

A balanced diet rich in antioxidants could potentially reduce the risk of cancer, although there are no specific dietary recommendations for the prevention of multiple myeloma. Regular exercise and a healthy body weight can also contribute to the dog’s overall health and well-being.

Avoiding known environmental toxins and carcinogens whenever possible can also be an important step in reducing the overall risk of cancer. This includes minimizing exposure to pesticides, certain chemicals, and tobacco smoke.

Outlook on current research

Multiple myeloma is a rare but significant disease in dogs that affects the bone marrow. Current research focuses on better understanding the genetic and molecular mechanisms involved in the development of this disease. One area of great interest is the identification of genetic predispositions that could make certain dog breeds more susceptible to multiple myeloma. By understanding these genetic factors, scientists hope to develop better diagnostic tools and targeted therapies.

Another focus of research is the exploration of new treatment methods. Traditionally, chemotherapy and radiation therapy have been used to treat multiple myeloma, but new approaches, such as immunotherapeutic treatments, are currently being investigated. These therapies aim to strengthen the dog’s immune system to fight the cancer cells more effectively. Initial studies have shown that immunotherapies have the potential to slow the progression of the disease and improve the quality of life of affected dogs.

In addition, researchers are working to identify biomarkers that allow multiple myeloma to be detected early. Currently, this disease is often diagnosed only in an advanced stage because the symptoms can be non-specific. By developing blood tests or other non-invasive methods for early detection, veterinarians could diagnose and treat the disease at an earlier stage, which could significantly improve the prognosis.

In the long term, research aims to develop personalized medicine for dogs with multiple myeloma. This would mean that the treatment is tailored to the specific genetic and molecular characteristics of each dog’s tumor. Such personalized approaches could increase the effectiveness of the treatment and minimize side effects.

Research on multiple myeloma in dogs is still in its early stages, but the progress made so far is promising. With the increasing availability of advanced genetic analysis techniques and the collaboration between veterinary physicians and oncologists, there is hope that significant breakthroughs can be achieved in the near future that will improve the lives of dogs with this disease.

Frequently asked questions (FAQs)

What is Multiple Myeloma? Multiple myeloma is a form of bone marrow cancer in which there is an uncontrolled proliferation of plasma cells. These cells are part of the immune system and produce antibodies. In multiple myeloma, however, abnormal antibodies are produced, which can lead to various health problems.
What symptoms occur in dogs with multiple myeloma? Dogs with multiple myeloma can show a variety of symptoms, including lethargy, weight loss, bone pain, lameness, increased susceptibility to infection, and in some cases, neurological symptoms. The symptoms can vary depending on the affected area in the body.
How is multiple myeloma diagnosed in dogs? The diagnosis of multiple myeloma is usually based on a combination of blood tests, urine analyses, X-rays, ultrasound, and sometimes a bone marrow biopsy. These tests help to determine the presence of abnormal plasma cells and the degree of organ involvement.
What treatment options are available for dogs with multiple myeloma? Treatment may include chemotherapy, radiation therapy, and supportive care. In some cases, new therapies such as immunotherapy may also be considered. The choice of treatment depends on the severity of the disease and the dog’s general health.
Is multiple myeloma curable in dogs? Multiple myeloma is currently considered incurable, but there are treatment options that can slow the progression of the disease and improve the quality of life. With the right therapy, many dogs can still live months to years in good quality of life.
Which dog breeds are particularly susceptible to multiple myeloma? Some studies suggest that certain breeds such as German Shepherds, Golden Retrievers, and Boxers may have a higher risk of developing multiple myeloma. This could be due to genetic factors that are still being explored.
How common is multiple myeloma in dogs? Multiple myeloma is relatively rare and accounts for only a small percentage of all malignant tumors in dogs. Nevertheless, it is a significant disease because it can have serious health consequences.
Can multiple myeloma be prevented in dogs? Currently, there are no specific measures to prevent multiple myeloma in dogs. However, a healthy lifestyle, regular veterinary check-ups, and early detection of symptoms can help to diagnose and treat the disease in a timely manner.
What role does nutrition play in dogs with multiple myeloma? A balanced diet can help support the overall health and well-being of dogs with multiple myeloma. It may be important to pay attention to a diet that strengthens the immune system and minimizes the side effects of treatment. However, the exact diet should be discussed individually with a veterinarian.
How can I help my dog with multiple myeloma? In addition to medical treatment, you can help your dog through love, attention, and care. Be sure to follow your veterinarian’s treatment recommendations closely and attend regular check-ups. A good quality of life and comfort are crucial for your dog’s well-being.